Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review
This systematic review evaluated 35 randomized controlled trials assessing the efficacy and safety of ketamine in treating Major Depressive Disorder (MDD). Intravenous (IV) ketamine demonstrated significant antidepressant effects in 70% of the studies, while oral and intranasal routes showed limited efficacy. Common adverse effects included nausea, vomiting, dizziness, diplopia, drowsiness,